Abstract
Abstract In January, the Iowa Pharmacy Association (IPA) held its annual Legislative Day, during which Iowa pharmacists met with their legislators to discuss the legislative priorities established by IPA's Legislative Committee and Board of Trustees. This was a particularly interesting session because in the previous year, both the Iowa House and Senate unanimously passed House File 2297 (HF 2297), which provided greater transparency of PBMs' practices to the Iowa Insurance Division (IID) and implemented changes related to maximum allowable cost pricing.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
